Packman
Aaron I. Packman, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20110081274 | UV disinfectant device for biofilm flow cell - A UV (ultraviolet) light disinfectant apparatus useful with a biofilm flow cell for in-line, non-invasive disinfecting of medium flow to and from the flow cell is provided. The disinfectant apparatus includes a UV chamber having a UV light source therein and one or more UV light-transmissive tubes that extend through the UV chamber and through which the fluid medium flows through the UV chamber for exposure to UV light for purposes of disinfectation. | 04-07-2011 |
Dagan Packman, Longmont, CO US
Patent application number | Description | Published |
---|---|---|
20080273115 | Multimedia presentation format - A format for accessing content such as a full-length move from an optical disc uses an XML description file stored on the disc to generate one or more screens that a user employs to access the content. The decoding requirements of a hardware or software player are reduced by discarding specific elements of an encoding standard such as MPEG4 that is used to encode the content on the disc. The maximum average and peak bitrates at which the data is transferred are limited to further reduce the demands on the player. | 11-06-2008 |
20090136218 | Multimedia presentation format - A format for accessing content such as a full-length movie from an optical disc uses an XML Description File stored on the disc to generate one or more screens that a user employs to access the content. To increase the efficiency of accessing data, data files that describe the content of the disc are located near the beginning of the video zone whereas larger data files, such as presentation files, are located at the end of the video zone. To reduce the possibility of incompatibilities between commands, a limited set of application program interface (API) commands is defined for use in an XML Description File. To maximize the vertical data recorded on the disc when the source aspect ratio is high, two, independent horizontal and vertical distortion factors are used. The audio and video tracks are interleaved into 1000 millisecond blocks and are demultiplexed by the application player during playback. | 05-28-2009 |
Dagan X. Packman, Longmont, CO US
Patent application number | Description | Published |
---|---|---|
20130339467 | Wireless Mobile Data Server With Removable Solid-State Memory - A battery operated, wireless mobile data server with an application processing environment and a relational database management system and removable solid-state memory for the distribution and recording of content accessible from clients consisting of multiple mobile devices such as smartphones, tablet computers, notebook computers and other mobile computing devices. The mobile data server can perform processing of application code and perform queries on relational databases and wirelessly provide access to large data sets independently to multiple mobile devices or in coordination to multiple mobile devices, irrespective of the mobile devices' operating systems within a defined geographic range without the use of a cellular infrastructure. | 12-19-2013 |
20140019588 | Distributed Local Text, Audio and Video And Application-Specific Messaging Service With Video Recording In A Battery-Operated Wireless Mobile Data Server With Removable Solid-State Memory Modules - A software application messaging service running on a battery operated, wireless mobile data server with an application processing environment and a relational database management system and removable solid-state memory for the distribution and recording of content accessible from clients consisting of multiple mobile devices such as smartphones, tablet computers, notebook computers and other mobile computing devices. Whereby this software messaging service enables software applications located on client devices to send and receive messages on a one-to-one, one-to-many, one-to-all, none-to-one, none-to-many or none-to-all basis, where the distribution of the message is determined by the software service via parsing of the message to identify intended client recipients. | 01-16-2014 |
Jay Packman, Montvale, NJ US
Patent application number | Description | Published |
---|---|---|
20090183636 | AIR PURIFIER DEVICE - The present invention is generally directed to devices useful in insuring the proper installation of a high efficiency particulate air (“HEPA”) filter into a room air purifier. In accordance with one aspect of the present invention, a magnetic interlock device is provided wherein the filter must be properly installed within the air purifier to enable closure of an electrical switch ( | 07-23-2009 |
Jay Packman, Suffem, NY US
Patent application number | Description | Published |
---|---|---|
20100239476 | CARTRIDGE-TYPE DISPENSER - The present invention relates to improved cartridge-type dispenser for a chemical treatment composition which, when contacted with water or other liquid will at least partially dissolve or disperse, and thereby elute one or more chemical compounds to the water or other liquid. The improved cartridge-type dispense may be used itself, or in conjunction with a further apparatus. | 09-23-2010 |
20110194993 | CARTRIDGE-TYPE DISPENSER - The present invention relates to improved cartridge-type dispenser for a chemical treatment composition which, when contacted with water or other liquid will at least partially dissolve or disperse, and thereby elute one or more chemical compounds to the water or other liquid. The improved cartridge-type dispense may be used itself, or in conjunction with a further apparatus. | 08-11-2011 |
Kathryn Packman, Bloomfield, NJ US
Patent application number | Description | Published |
---|---|---|
20120045433 | COMBINATION THERAPY - The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an topoisomerase inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the topoisomerase inhibitor is irinotecan, or a pharmaceutically acceptable salt thereof, and the disorder is colorectal cancer involving a tumor comprising b-Raf having the V600E mutation. | 02-23-2012 |
20120045434 | COMBINATION THERAPY - The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. | 02-23-2012 |
20120148533 | COMBINATION THERAPY - The present invention relates to a combination therapy of propane-1-sulfonic acid{3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}, or a pharmaceutically acceptable salt thereof, and an interferon for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the interferon is peginterferon alfa-2a and the disorder is melanoma containing the V600E b-Raf mutation. | 06-14-2012 |
20130245039 | COMBINATION THERAPY FOR PROLIFERATIVE DISORDERS - Treatment of proliferative diseases with a combination of a b-Raf inhibitor and MDM2 inhibitor. | 09-19-2013 |
20130245089 | METHOD FOR ADMINISTRATION - There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels. | 09-19-2013 |
Kathryn E. Packman, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20140370019 | BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5, ANTIBODIES SPECIFIC FOR DR5 AND METHODS OF USE - The present invention relates to bispecific antibodies comprising at least one antigen binding site specific for DR5 and at least one antigen binding site specific for FAP, antibodies specific for DR5, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 12-18-2014 |
Kathyrn Elizabeth Packman, Bloomfield, NJ US
Patent application number | Description | Published |
---|---|---|
20090181944 | METHOD FOR CANCER THERAPY - The present invention provides a method for treating a patient having cancer comprising administering to the patient a therapeutically effective amount of compound (1), or a pharmaceutically acceptable salt thereof, having the formula: | 07-16-2009 |
20130281437 | METHOD FOR CANCER THERAPY - The present invention provides a method for treating a patient having cancer comprising administering to the patient a therapeutically effective amount of compound (1), or a pharmaceutically acceptable salt thereof, having the formula: | 10-24-2013 |